Global reach. Local expertise.
With offices across North America and Europe our consultants and strategic advisors bring local insights and expertise to ensure the greatest opportunity for success of your product, regardless of the geographic market you’re looking to enter.
500+
Associates worldwide
30+
Global markets covered
235+
Brands represented
Market research and advisor networks
Conduct research with our prestigious advisor networks and tap into insights from healthcare's most respected authorities and decision makers. Whether you need to gather payer insights, capture provider and practice behaviors, or acquire specific knowledge of submission processes around the world, engage with our industry experts for critical guidance that drives product success.
Our businesses
Innomar Strategies
Our businesses
TPI Reg
TPIreg™ provides Regulatory Affairs services for prescription and non-prescription pharmaceuticals and biologics, medical devices, combination products, natural health products, and cosmetics. The Regulatory Team includes members skilled in clinical/non-clinical, chemistry manufacturing and control (CMC), risk management, and labelling.
Maximize brand visibility
Exchange information with thousands of payers
FormularyDecisions is a secure, online platform facilitating the bi-directional exchange of information between life sciences companies and over 2,400 qualified, active healthcare decision-makers. From pre-approval to post-launch, get unrivaled insight into what payers think of your product and those of your competitors, and gain feedback to better inform your market access strategies.
Featured Insights
Keep up on key global health technology assessment news
HTA Quarterly
Each edition of HTA Quarterly provides insights and analysis from global experts with local market expertise on key priorities and perspectives affecting HTA.
From therapeutic area spotlights to geographic reviews to critical industry topics, keep current on HTA activity around the globe with HTA Quarterly.
Health Policy Weekly
Health Policy weekly recaps legislative and regulatory developments and healthcare reform news that impacts the healthcare industry, particularly pharmaceutical, biotech, and device manufacturers, providers, and managed care.
Developed by a multi-disciplinary editorial board that includes health policy and reimbursement strategy experts, Health Policy Weekly delivers key insights to your inbox every week.
Developed by a multi-disciplinary editorial board that includes health policy and reimbursement strategy experts, Health Policy Weekly delivers key insights to your inbox every week.
